Global Tissue Engineered Skin Substitutes Market by Product (Biosynthetic, Synthetic, Biological), by Application (Chronic Wounds, Acute Wounds) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global tissue engineered skin replacements market was worth USD 661 million in 2019. It is projected to grow at a compound annual rate (CAGR of 4.7%) between 2020 and 2027. Tissue engineered skin replacements are in high demand due to technological advances in healthcare, the increasing prevalence of chronic and acute wounds, high demand skin grafts and increasing awareness about various treatment options.

Tissue engineered skin replacements will also be in demand due to the rising incidence of injuries such as burns and road accidents. According to WHO (2018), burns are the second most common injury in Nepali rural areas and account for 5.0% of all disabilities. According to the American Burn Association, 486,000 burn injuries were treated in the U.S. in 2016. According to the WHO, almost 1.4 million people are killed each year in road traffic accidents. The WHO also stated that road accidents are the leading cause for death among children and adults between 5 and 29 years old. A majority of skin grafts are used to treat acute wounds. Treatments for moderate and severe burns can be done with biosynthetic or synthetic tissue engineered skin replacements. Biosynthetic skin substitutes can also be used in large-sized wound healing operations. The rising incidence of accidents will likely increase demand for tissue-engineered skin substitutes. This is expected to result in significant market growth during the forecast period.

The market for tissue engineered skin replacements will be driven by increasing awareness about the various treatments available. This is due to the increasing willingness of people to spend more on advanced burn care products. Majorly, synthetic and biosynthetic skin grafts can be used to treat moderate and severe burns. First-degree burns can be treated with biological tissue engineered skin replacements.

Awareness levels are also increased by the presence of non-profit organizations, such as the American Burn Association (ABA), and the World Health Organization(WHO). In order to improve the treatment of burn injuries worldwide, The International Society for Burn Injuries has collaborated with the WHO. To ensure safety and effectiveness, the FDA (U.S. Food and Drug Administration) uses the scientific review process to approve Class III medical devices before they go on sale. Tissue-engineered skin substitutes fall under the Class III medical device classification. Apligraf, Dermagraft and Integra Omnigraft Derma Regeneration Matrix are some of the FDA-approved tissue engineered skin replacements.

Non-profit organizations like the British Burn Association (BBA), which promotes knowledge about the best treatment for burn injuries, and the Canadian Association of Burn Nurses(CABN), which provides nurses who can treat burn patients, are increasing awareness of burn care.

Product Insights

The market for tissue-engineered skin substitutes can be divided into three segments based on product: biosynthetic, synthetic, or biological. Due to an increasing prevalence of acute wounds around the world, the market for biological tissue engineered skin replacements held the largest share in 2019. Biological tissue engineered skin alternatives have the advantage that they can be obtained directly from patients. Biotissue engineered skin substitutes have a greater extracellular matrix which facilitates faster wound healing and excellent re-epithelialization.

The segment of synthetic tissue engineered skin replacement is expected to experience the fastest growth over the forecast period. This segment's growth is due to technological advances in healthcare. Synthetic tissue engineered skin alternatives have greater control over the composition of the scaffold. Market growth is being driven by technological advances in tissue engineered skin replacements like collagen-synthetic-bilaminates, and tissue culture-derived membranes.

Application Insights

The tissue engineered skin replacements market can be divided into two segments based on their application: acute and chronic wounds. A rising number of surgeries combined with the growing prevalence of burn injuries meant that the market share for the acute wound segment was the highest in 2019. According to the American Burn Association in the United States, burn injuries are a major cause of unintentional death and injury. This segment can be further divided into surgery, trauma, and burn injury.

The fastest growing segment in the future is the chronic wound segment. Tissue-engineered skin substitutes are used to treat extreme cases of diabetic feet ulcers, pressure and venous leg injuries. This procedure uses a lot of biologically engineered skin substitutes.

End-Use Information

Due to the increasing number of surgeries around the world, the hospital segment accounted for the highest revenue share in 2019. This segment is driven by the increasing incidence of diabetic foot ulcers, and venous legs ulcers. The segment is also driven by an increasing number of surgical wounds as a result of increased surgeries.

Over the forecast period, significant growth is expected in the section of wound care centers. Wound care centers provide wound treatment services. Although wound care centers are still relatively new in many countries, they are quickly gaining popularity. This segment is expected to see significant growth during the forecast period.

Regional Insights

North America's market for tissue-engineered skin substitutes accounted for the highest revenue share in 2019. This is due to technological advances in the healthcare sector, an increase in burn injuries and the presence key players in the region. The market is expected to grow in North America due to increasing sports injuries, road accidents, as well as the presence of key players in the region. The market will also be driven by the availability of skilled workers and improvements in healthcare infrastructure over the forecast period.

The Asia Pacific region is expected to experience the fastest growth rate during the forecast period. Market growth is expected to be boosted by the presence of developing countries like China, India, Japan. The rapid growth of medical tourism in these countries can also attributed to the increased demand for tissue-engineered skin replacements in the region.

Market Share Insights & Key Companies

The key players in the market are involved in launching new products, mergers and acquisitions, partnerships and other strategies to increase their market share. They are also investing heavily in research and development to produce technologically advanced products. The market for tissue engineered skin replacements is dominated by the following players:

• Amarantus BioScience Holdings

• Organogenesis, Inc.

• KCI Licensing, Inc.

• Smith and Nephew

• BSN in medical

• Molnlycke Health Care AB

• Integra LifeSciences Corporation

• Medtronic

• Tissue Regenix

Up Market Research published a new report titled “Tissue Engineered Skin Substitutes Market research report which is segmented by Product (Biosynthetic, Synthetic, Biological), by Application (Chronic Wounds, Acute Wounds), By Players/Companies KCI Licensing Inc, M¶lnlycke Health Care AB, Organogenesis Inc, Smith and Nephew, Medtronic, Tissue Regenix, Amarantus BioScience Holdings, BSN medical, Integra LifeSciences Corporation”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Tissue Engineered Skin Substitutes Market Report Segments:

The market is segmented by Product (Biosynthetic, Synthetic, Biological), by Application (Chronic Wounds, Acute Wounds).

Tissue Engineered Skin Substitutes Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Tissue Engineered Skin Substitutes Market

Overview of the regional outlook of the Tissue Engineered Skin Substitutes Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Tissue Engineered Skin Substitutes Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Tissue Engineered Skin Substitutes Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Biosynthetic

                2. Synthetic

                3. Biological

                1. Chronic Wounds

                2. Acute Wounds

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Tissue Engineered Skin Substitutes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Tissue Engineered Skin Substitutes Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.